Clinical Trial Update: Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 trial evaluating S-1 in combination with paclitaxel for advanced esophageal cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Peking University | Conditions: Esophageal Cancer | Phase 2, Phase 3 | Status: TERMINATED